Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16797587rdf:typepubmed:Citationlld:pubmed
pubmed-article:16797587lifeskim:mentionsumls-concept:C0002716lld:lifeskim
pubmed-article:16797587lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:16797587lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:16797587lifeskim:mentionsumls-concept:C0332621lld:lifeskim
pubmed-article:16797587pubmed:issue4lld:pubmed
pubmed-article:16797587pubmed:dateCreated2006-7-10lld:pubmed
pubmed-article:16797587pubmed:abstractTextAmyloid fibrils are insoluble mainly beta-sheet aggregates of proteins or peptides. The multi-step process of amyloid aggregation is one of the major research topics in structural biology and biophysics because of its relevance in protein misfolding diseases like Alzheimer's, Parkinson's, Creutzfeld-Jacob's, and type II diabetes. Yet, the detailed mechanism of oligomer formation and the influence of protein stability on the aggregation kinetics are still matters of debate. Here a coarse-grained model of an amphipathic polypeptide, characterized by a free energy profile with distinct amyloid-competent (i.e. beta-prone) and amyloid-protected states, is used to investigate the kinetics of aggregation and the pathways of fibril formation. The simulation results suggest that by simply increasing the relative stability of the beta-prone state of the polypeptide, disordered aggregation changes into fibrillogenesis with the presence of oligomeric on-pathway intermediates, and finally without intermediates in the case of a very stable beta-prone state. The minimal-size aggregate able to form a fibril is generated by collisions of oligomers or monomers for polypeptides with unstable or stable beta-prone state, respectively. The simulation results provide a basis for understanding the wide range of amyloid-aggregation mechanisms observed in peptides and proteins. Moreover, they allow us to interpret at a molecular level the much faster kinetics of assembly of a recently discovered functional amyloid with respect to the very slow pathological aggregation.lld:pubmed
pubmed-article:16797587pubmed:languageenglld:pubmed
pubmed-article:16797587pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16797587pubmed:citationSubsetIMlld:pubmed
pubmed-article:16797587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16797587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16797587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16797587pubmed:statusMEDLINElld:pubmed
pubmed-article:16797587pubmed:monthJullld:pubmed
pubmed-article:16797587pubmed:issn0022-2836lld:pubmed
pubmed-article:16797587pubmed:authorpubmed-author:CaflischAmede...lld:pubmed
pubmed-article:16797587pubmed:authorpubmed-author:PellarinRicca...lld:pubmed
pubmed-article:16797587pubmed:issnTypePrintlld:pubmed
pubmed-article:16797587pubmed:day21lld:pubmed
pubmed-article:16797587pubmed:volume360lld:pubmed
pubmed-article:16797587pubmed:ownerNLMlld:pubmed
pubmed-article:16797587pubmed:authorsCompleteYlld:pubmed
pubmed-article:16797587pubmed:pagination882-92lld:pubmed
pubmed-article:16797587pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16797587pubmed:meshHeadingpubmed-meshheading:16797587...lld:pubmed
pubmed-article:16797587pubmed:meshHeadingpubmed-meshheading:16797587...lld:pubmed
pubmed-article:16797587pubmed:meshHeadingpubmed-meshheading:16797587...lld:pubmed
pubmed-article:16797587pubmed:meshHeadingpubmed-meshheading:16797587...lld:pubmed
pubmed-article:16797587pubmed:meshHeadingpubmed-meshheading:16797587...lld:pubmed
pubmed-article:16797587pubmed:meshHeadingpubmed-meshheading:16797587...lld:pubmed
pubmed-article:16797587pubmed:year2006lld:pubmed
pubmed-article:16797587pubmed:articleTitleInterpreting the aggregation kinetics of amyloid peptides.lld:pubmed
pubmed-article:16797587pubmed:affiliationDepartment of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.lld:pubmed
pubmed-article:16797587pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16797587pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16797587lld:pubmed